Bill of Health

APRIL 6, 2022

It only narrowly modifies compulsory licenses of patents covering COVID vaccines. Moreover, it imposes additional restrictions on use of compulsory licenses. IP on COVID vaccines should be a global public good. This is true not just for COVID, but future pandemics. We need a new approach.

COVID-19 309

COVID-19 Licensing COVID-19 Vaccine Public Health 309

Bill of Health

MARCH 24, 2022

Consider, for instance, the case of COVID-19 vaccines. Even those relying on a new type of vaccine technology, such as mRNA vaccines , resulted from well over a decade of R&D in mRNA vaccinology and used vaccine components that were developed well before the COVID-19 pandemic began.

COVID-19 Vaccine 130

COVID-19 Vaccine Licensing COVID-19 Public Health 130

Bill of Health

AUGUST 29, 2022

On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. As a result, it publicly promised that “ while the pandemic continues, Moderna will not enforce our COVID-19 related patents against those making vaccines intended to combat the pandemic.”

COVID-19 Vaccine 362

COVID-19 Vaccine COVID-19 Licensing Governance 362

Bill of Health

SEPTEMBER 20, 2022

By December 2020, the world had astonishingly powerful tools against COVID-19. New mRNA vaccines, underpinned by decades of public investment , had been authorized by global regulators. By May 12, 2022, over 40 percent of national COVID-19 deaths were caused by WHO-designated variants. By Zain Rizvi.

Public Health 246

Public Health COVID-19 World Health Governance 246

Health Law RX

NOVEMBER 5, 2021

The first rule, issued by the Occupational Safety and Health Administration (the “OSHA Rule”), will require private employers with 100 or more employees to ensure that each of their workers is either fully vaccinated, or tests negative for COVID-19 at least once per week. The OSHA Rule. and wear a face covering.”

COVID-19 40

COVID-19 COVID-19 Vaccine ADA Medicaid 40